# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Macquarie analyst Frederick Havemeyer downgrades UiPath (NYSE:PATH) from Outperform to Neutral and lowers the price target f...
BMO Capital analyst Keith Bachman maintains UiPath (NYSE:PATH) with a Market Perform and lowers the price target from $28 to...
Canaccord Genuity analyst Kingsley Crane maintains UiPath (NYSE:PATH) with a Buy and lowers the price target from $30 to $19.
On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhoo...